# Study of PEG-Intron for Plexiform Neurofibromas

> **NCT00396019** · PHASE2 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 86 (actual)

## Conditions studied

- Plexiform Neurofibroma

## Interventions

- **DRUG:** PEG-Intron

## Key facts

- **NCT ID:** NCT00396019
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396019, "Study of PEG-Intron for Plexiform Neurofibromas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00396019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*